AvenAo Industrie has sold Prod IG to 1Life
AvenAo Industrie (AvenAo), an expert in industrial innovative solutions, has sold Prod-IG to 1Life, an integrator of management solutions, for an undisclosed consideration.
ProdIG is a value-added reseller of the Yourcegid Manufacturing ERP solution, edited by Cegid.
1Life is the main reseller of Yourcegid Manufacturing PMI ERP (edited by Cegid), offering complementary and innovative modules. The company serves its clients through its teams in Lyon, Paris, Nantes and Montpellier.
AvenAo, an expert in industrial innovative solutions, offers global support to professionals and their innovation projects. The group is specialized in advisory and integration in technological solutions along the value chain: conception, production management and additive manufacturing. AvenAo, with 15 years' experience, has 130 employees, 12 agencies in France and Belgium, five entities (A-S3D, 3dservicad, Creatix3D, Prod-IG, LDM Factory) and serves 3,000 customers.
Oaklins's team in France advised the seller in this transaction.
Talk to the deal team
Related deals
BodhiCedric has acquired Network Media from Jellysmack
The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.
Learn moreCustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more